Asciminib is safe and effective in patients with newly diagnosed CML
Crossref DOI link: https://doi.org/10.1038/s41571-024-00919-6
Published Online: 2024-06-25
Published Print: 2024-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Romero, Diana
Text and Data Mining valid from 2024-06-25
Version of Record valid from 2024-06-25
Article History
First Online: 25 June 2024